To promote eye care around the world SC&H Capital recently facilitated the sale of Baltimore-based nonprofit KeraLink International. SC&H Capital served as the exclusive financial advisor to KeraLink. To create greater eye banking efficiencies domestically and to provide more opportunities to restore sight to more people internationally, KeraLink has transferred its domestic eye banking operations to another industry leader, CorneaGen.
“This important sale will help us to maintain and build upon our record of successfully treating patients. KeraLink’s history in this field is unrivaled, and this deal will provide the resources to do even more to restore sight to the blind,” said Douglas Furlong, KeraLink’s President and Chief Executive Officer. “And, of course, we’re grateful to SC&H Capital for helping us and, way more importantly, helping people around the world. Being able to see should not depend on where you were born.”
“This deal will enable a tremendous expansion of KeraLink’s efforts around the world to reverse corneal blindness. We are so proud and fortunate to have worked with these devoted professionals to further enhance patient health,” said Christopher Helmrath, Managing Director, SC&H Capital.
